( in Million)
Particulars
Mar 2026
Dec 2025
Sep 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
352.1
67.34
71.66
75.76
Total Expenditure
314.36
113.63
60.78
63.34
PBIDT (Excl OI)
37.74
-46.29
10.88
12.42
Other Income
26.72
18.37
38.67
74.54
Operating Profit
64.47
-27.92
49.55
86.96
Exceptional Items
NA
NA
NA
NA
PBDT
64.47
-27.92
49.55
86.96
Depreciation
0.52
0.45
0.43
0.55
Profit Before Tax
63.95
-28.37
49.12
86.41
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
39.47
-29.28
34.4
126.67
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
39.47
-29.28
34.4
126.67
Minority Interest
-17.4
10.13
-8.51
-3.98
Shares of Associates
0.1
-0.03
0.94
0.08
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
22.17
-19.18
26.83
122.78
Equity Capital
628.08
628.08
628.08
628.08
Calculated EPS
0.07
-0.06
0.08
0.39
Calculated EPS (Annualised)
0.28
-0.24
0.34
1.56
No of Public Share Holdings
155699588
155699588
155699588
155699588
% of Public Share Holdings
49.58
49.58
49.58
49.58
PBIDTM% (Excl OI)
10.71
-68.74
15.18
16.39
PBIDTM%
18.31
-41.46
69.14
114.78
PBDTM%
18.31
-41.46
69.14
114.78
PBTM%
18.16
-42.12
68.54
114.05
PATM%
11.20
-43.48
48.00
167.19